Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03843294
Title Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Catherine Bollard

diffuse large B-cell lymphoma

Hodgkin's lymphoma


MultiTAA-specific T cells + Nivolumab

Age Groups: adult | child | senior
Covered Countries USA

No variant requirements are available.